Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Evaluation of the Adaptilens Accommodating IOL

NCT: NCT07607860 · NOT_YET_RECRUITING

NCT IDNCT07607860
StatusNOT_YET_RECRUITING
SponsorAdaptilens, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The goals of this feasibility study are to learn more about the performance of the intraocular lens (IOL), if the IOL is safe for use, and what the best surgical techniques are for implanting the IOL in patients who require correction of aphakia following phacoemulsification extraction of a senile cataract.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑